Eikon Therapeutics has a total of 6 patents globally, out of which 4 have been granted. Of these 6 patents, all patents are active. United States of America is where Eikon Therapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Eikon Therapeutics.
Eikon Therapeutics was founded in the year 2019. The Company operates as a biopharmaceutical company. The Company focuses on discovering treatments for life-threatening diseases.
Do read about some of the most popular patents of Eikon Therapeutics which have been covered by us in this article and also you can find Eikon Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Eikon Therapeutics patent portfolio.
How many patents does the founder and the CEO of Eikon Therapeutics have?
The founder Eric Betzig has 10 patents and CEO Roger Perlmutter has 0 patent.
How many patents does Eikon Therapeutics have?
Eikon Therapeutics has a total of 6 patents globally. These patents belong to 3 unique patent families. Out of 6 patents, all patents are active.
How Many Patents did Eikon Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Eikon Therapeutics Applications Filed||Eikon Therapeutics Patents Granted|
How many Eikon Therapeutics patents are Alive/Dead?
All the Patents were filed by Eikon Therapeutics are Alive.
How Many Patents did Eikon Therapeutics File in Different Countries?
All the Patents were filed by Eikon Therapeutics in the United States of America.
Where are Research Centres of Eikon Therapeutics Patents Located?
The Research Centre for all the Eikon Therapeutics patents is the United States of America.
List of Eikon Therapeutics Patents
|Eikon Therapeutics Patents||Title|
|US10010554B2||Fused Pyrimidines As Inhibitors Of P97 Complex|
|US9868722B2||Monocyclic Pyrimidine/Pyridine Compounds As Inhibitors Of P97 Complex|
|US9475824B2||Fused Pyrimidines As Inhibitors Of P97 Complex|
|US9062026B2||Fused Pyrimidines And Substituted Quinazolines As Inhibitors Of P97|
|US20230086732A1||Photoactive Fluorescent Compounds And Use Thereof For Labeling Of Proteins|
|WO2023009503A1||2-Diazo-3-Oxo-2,3-Dihydrospiro[Indene-1,9′-Xanthene] Derivatives And Similar Compounds As Photoactive Fluorescent Compounds For Protein Labeling|
What are Eikon Therapeutics key innovation segments?
What Technologies are Covered by Eikon Therapeutics?
The chart below distributes patents filed by Eikon Therapeutics